Valuation: Physiomics Plc

Market Cap 2.15M 2.88M 2.51M 2.37M 4.03M 276M 4.05M 28.4M 10.96M 140M 10.82M 10.58M 452M P/E 2024
-2.67x
P/E 2025 -2.67x
Enterprise Value 1.7M 2.27M 1.98M 1.87M 3.18M 218M 3.19M 22.37M 8.63M 111M 8.52M 8.33M 356M EV / Sales 2024
2.52x
EV / Sales 2025 1.14x
Free-Float
74.27%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Physiomics Plc

Current month+1.94%
1 month+11.70%
6 months+23.53%
Current year+84.21%
1 week 0.5
Extreme 0.5
0.55
1 month 0.45
Extreme 0.447
0.65
Current year 0.25
Extreme 0.2525
0.8
1 year 0.25
Extreme 0.2525
0.8
3 years 0.25
Extreme 0.2525
3.19
5 years 0.25
Extreme 0.2525
7.25
10 years 0.25
Extreme 0.2525
32
Manager TitleAgeSince
Director of Finance/CFO 52 -
Chief Operating Officer - 30/06/2026
Corporate Officer/Principal - 30/08/2021
Director TitleAgeSince
Director/Board Member - 28/04/2026
Chairman 53 28/04/2026
Director/Board Member - 28/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/07/26 Buy

Director

3,000,000 0.6619%
10/07/26 Buy

Director

1,111,111 0.2452%
08/11/24 Buy

Chief Executive Officer

459,090 0.2259%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-72.37% 3.18M
+0.30%-1.31%-20.18%+4.06% 119B
-5.05%-2.04%-41.30%-25.96% 43.1B
+0.62%-0.31%-0.56%+3.71% 39.95B
-1.43%-5.99%-39.06%-18.51% 18.94B
-2.74%+2.90%-41.49%-41.92% 17.93B
+0.02%+3.44%+10.66%+57.25% 16.82B
-0.93%-6.78%-21.66%-7.35% 14.01B
+1.79%+9.29%-5.78%-33.87% 9.92B
+6.83%+9.82%+12.51%+100.07% 4.35B
Average -0.06%+1.68%-14.69%-3.49% 28.41B
Weighted average by Cap. -0.70%+0.26%-20.47%-2.22%

Financials

2024 2025
Net sales 571K 763K 665K 628K 1.07M 73.22M 1.07M 7.53M 2.9M 37.23M 2.87M 2.8M 120M 834K 1.12M 973K 919K 1.56M 107M 1.57M 11M 4.25M 54.43M 4.19M 4.1M 175M
Net income -609K -815K -711K -671K -1.14M -78.2M -1.15M -8.04M -3.1M -39.76M -3.06M -2.99M -128M -415K -555K -484K -457K -778K -53.29M -781K -5.48M -2.11M -27.09M -2.09M -2.04M -87.18M
Net Debt -187K -250K -218K -206K -351K -24.03M -352K -2.47M -953K -12.22M -941K -920K -39.31M -457K -612K -533K -504K -857K -58.69M -860K -6.03M -2.33M -29.84M -2.3M -2.25M -96M
Logo Physiomics Plc
Physiomics PLC is a United Kingdom-based company, which provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology. The Company offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). It is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The Company is also developing its technology for use in the field of personalized medicine. The Company is focused on helping pharma and biotech clients.
Employees
10
Date Price Change Volume
18/09/26 GBX 0.5250 0.00% 1,702,733
17/09/26 GBX 0.5250 0.00% 2,991,992
16/09/26 GBX 0.5250 0.00% 529,252
15/09/26 GBX 0.5250 0.00% 6,910,912
14/09/26 GBX 0.5250 0.00% 1,252,602

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!